KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pitney Bowes (PBI) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Pitney Bowes (PBI) over the last 17 years, with Q3 2025 value amounting to $321.0 million.

  • Pitney Bowes' Cash & Equivalents fell 4283.66% to $321.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $321.0 million, marking a year-over-year decrease of 4283.66%. This contributed to the annual value of $469.7 million for FY2024, which is 2171.94% down from last year.
  • Pitney Bowes' Cash & Equivalents amounted to $321.0 million in Q3 2025, which was down 4283.66% from $285.2 million recorded in Q2 2025.
  • Pitney Bowes' 5-year Cash & Equivalents high stood at $799.5 million for Q2 2021, and its period low was $285.2 million during Q2 2025.
  • Its 5-year average for Cash & Equivalents is $562.0 million, with a median of $570.7 million in 2022.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 894.27% in 2024, then crashed by 5167.7% in 2025.
  • Over the past 5 years, Pitney Bowes' Cash & Equivalents (Quarter) stood at $732.5 million in 2021, then fell by 8.76% to $668.3 million in 2022, then fell by 10.22% to $600.1 million in 2023, then fell by 21.72% to $469.7 million in 2024, then tumbled by 31.66% to $321.0 million in 2025.
  • Its Cash & Equivalents stands at $321.0 million for Q3 2025, versus $285.2 million for Q2 2025 and $323.8 million for Q1 2025.